The cDNA encoding adenovirus E1A enhancer-binding protein E1A-F was isolated by screening a HeLa cell \gt11 expression library for E1A-F site-specific DNA binding. One cDNA clone produced recomblnant E1A-F protein with the same DNA binding specificity as that endogenous to HeLa cells. Sequence analysis of the cONA showed homology with the ETS-domaln, a region required for sequence-specific DNA binding and common to all ets oncogene members. Analysis of the longest cDNA revealed about a 94% Identity in amino acids between human E1A-F and mouse PEA3 (polyomavlrus enhancer activator 3), a recently characterized ets oncogene member. E1A-F was encoded by a 2.5kb mRNA in HeLa cells, which was found to Increase during the early period of adenovirus infection. In contrast, ets-2 mRNA was significantly reduced in infected HeLa cells. The results indicate that E1A enhancer binding protein E1A-F Is a member of the ets oncogene family and Is probably a human homologue of mouse PEA3.
INTRODUCTION
The adenovims(Ad) El A gene is the first transcription unit to be activated in productive infection. The El A gene encodes a potent activator for transcription of viral early and late genes(l). Defects of the E1A gene cause delayed onset of transcription from other early genes, E1B through E4, and viral mutants grow at extremely reduced levels (2, 3) . At least four separate enhancer elements are required for active transcription of the adenovirus type 5(Ad5) E1A gene (4) (5) (6) (7) . Transient expression assay with a series of deletion plasmids has showed a far upstream enhancer element, located around position -340 relative to the El A cap site(4). Hearing and Shenk found element I of El A enhancer at two separate sites, positions -200 and -300(5,6); Ad5 mutants with deletions of either copy of the element I produce low levels of ElA-specific mRNA. Recent analysis of viral mutants has showed transcriptional significance of an another copy of element I, located at position -270(7).
We have previously identified at least twenty-one proteinbinding sites on the upstream region of the Ad5 El A gene (8) . Several of those contain sequences identical or similar to the sequence recognized by transcription factors such as ATF (9) , NFm(Oct-l)(10) and E2F (11) . Interestingly, the factor bound to copies of the El A enhancer element I and far upstream enhancer was recovered in a single fraction of heparin-agarose chromatography (8) . Nucleotide sequences involved in protein-DNA contacts were similar with each other (8, 12) . These suggest El A enhancer elements may interact with common factors). El A enhancer elements contain core binding sequences 5'-A / c GGA A / T GT-3' (3, 4, 12) , which overlap the sequence recognized by ets oncogene family members. Several ets-related genes encode putative transcription factors for viral and cellular genes (13) . The ets-l is a cellular proto-oncogene of the \-ets of avian leukosis virus E26 (14) . Exogenous expression of the ets-l activates the polyomavirus enhancer through site-specific DNA binding (15) . The ets-l as well as AP-1 binding sequences mediates serum and oncogene-induced activation of some cellular genes (16) . The ets oncogene family may play a critical role in cell growth regulation (17) .
Here, we have isolated the cDNA encoding Ad5 E1A enhancer-binding protein (called El A factor: E1A-F) from a HeLa cell Xgtl 1 expression library by utilizing its ability to bind E1A-F sites. The cloned cDNA contained the ETS-domain, a region conserved in all ets oncogene members and required for specific DNA binding. Deduced amino acid sequences showed significant homology with recently characterized mouse PEA3, a member of the ets oncogene family.
MATERIALS AND METHODS
Cloning of the E1A-F cDNA A HeLa cell cDNA expression library in Xgtl 1 vector (Clontech Laboratories.Inc.) was screened using in situ sequence-specific DNA binding activity as described (18) . Screening was carried out with a 5'end-labeled DNA probe containing six tandem E1A enhancer elements (F-wt:5'-ACAGGAAGTGACACGGATGT GGC-3', core sequences are underlined) and four tandem mutant sequences (F-mut5'-ACACCAAGTGACACCCATGTGGC-3 r ). After four rounds of plaque-purification, the cDNA insert was cleaved out with EcoRI digestion, recloned into pUC119 and sequenced by the dideoxy method (19) . The isolated cDNA was used as a probe for further screening of the HeLa cell Xgtll library by plaque hybridization and the KB cell cDNA library in pCD vector by colony hybridization to isolate longer cDNA. These cDNA were also recloned into pUC119 or pUCl 18 and sequenced.
For DNA binding specificity, Y1089 lysogens were isolated (20) . Induced synthesis of /S-galactosidase fusion proteins with Isopropyl /3-D(-)-Thiogalactopyranoside (IPTG) was carried out as described (18) . Cells from 4 ml aliquots of the induced lysogen cultures were rapidly pelleted and resuspended in 50 IJI of lysis buffer (50 mM Tris pH 7.5, lmM EDTA, lmM DTT, 0. lmM aPMSF). Cell suspensions were subjected to three cycles of freezing and thawing. After a 30 min spin in a microfuge at 4°C, the supernatants were directly used for gel retardation and methylation interference assays.
Gel retardation assay
Standard binding reactions containing the /3-galactosidase fusion protein and 5'-end labeled probes were carried out in 15 /il mixtures in binding buffer (20mM Hepes-NaOH pH 7.8, 50mM NaCl, 0.5mM EDTA, 5% glycerol, 2/tg of poly dl-dC/dl-dC and 6/il of die lysogen extract). For competitions, 5 -200 fold molar excess amounts of DNA were added into the reaction mixtures. The mixtures were kept on ice for 10 min and then P-labeled DNA probe (~0.5ng) was added. After incubation for 15 min at room temperature, DNA-protein complex was resolved in 4% non-denaturing polyacrylamide gel.
Methylation interference assay
DNA labeled at the 5' end was partially methylated by treating for 3 min with 1/tl Dimethyl sulfate(DMS) as described (21) . After ethanol-precipitation twice, DNA was incubated with the lysogen extract and electrophoresed in 4% non-denaturing polTyacrylamide gel. After short term autoradiography, DNA was eluted from the region of gels containing free DNA and protein-DNA complexes as described (22) . DNA was purified from co-eluted acrylamide by a NACS column chromatography(BRL) according to the supplier's manual. DNA was cleaved with 100 /J of 1M piperidine and equal amounts of DNA (in cerenkov count) were electrophoresed in 12% polyacrylamide sequencing gels containing 8M urea with A + G Marker.
DNA sequencing
DNA sequencing was performed by the dideoxy sequencing method (19) , according to the suppliers manual (U.S.B.corp.). The longest cDNA clone was sequenced with Applied Biosystems Model 373A auto-sequencer.
Construction of effector and reporter plasmids
The expression vector pSTC contains the human CMV promoter, HSV tk gene 5' untranslated leader and initiation codon, rabbit /3-globin gene splicing and polyadenylation signals, and the replication origin of SV40 (23) . To produce the pCMVElA-F plasmid, the El A-F cDNA coding sequences were cut out from the longest cDNA clone with Eco47HI and Xbal, filled in with Klenow enzyme, and inserted into the Smal site of the pSTC plasmid. The coding sequences begin at the tk gene AUG codon and encode an extra 7 N-terminal amino acid and 453 amino acids long El A-F protein. The chloramphenicol acetyltransferase (CAT) expression plasmids were constructed by inserting three or six copies of the wild type El A enhancer core element (F-wt) or two copies of the mutated version (F-mut) into the unique BgUI site of the SV40 early core promoter-CAT (pA10CAT2, ref. 24) .
DNA transfection and CAT assay
Human 293 cells(5 X lO^r 10cm plate), were co-transfected with 5.0/xg of a reporter CAT plasmid, 2.5/xg of the pCMVElA-F plasmid and 5.0/tg of the pRSV-/3gal plasmid by using the calcium phosphate-DNA coprecipitation method (25) . Cells were harvested 48hr post-transfection and lysed by three successive cycles of freezing and thawing. Cell extracts were assayed for CAT activity by incubation with acetyl coenzymeA and [ 14 C] chloramphenicol(26), followed by diin-layer chromatography and quantitated by cutting the radioactive spots out of the plates after autoradiography. /3-Galactosidase activity was determined by using 0-nitrophenyl-/9-r>galactopyranoside as a substrate. CAT activity was corrected for differences in transfection efficiency by normalizing to /3-galactosidase activity.
Northern blot hybridization
HeLa cells were infected with human Ad5 (strain 300) at 20 plaque-forming units (PFU)/cell or with Ad5 dl312 (El A genedeleted mutants) at 50 PFU/cell. Cells were suspended in hypotonic buffer and lysed with 0.5% MM0 (27) . Cytoplasmic RNA was extracted twice with phenol/chloroform mixture and precipitated with 2 volumes of ethanol. RNA (20/ig/lane) was applied to 1.4% agarose gels containing 2.2M formaldehyde in MOPS-running buffer(28), transferred onto nitrocellulose filter (S&S, BA85) and probed in high stringency with 32 P-DNA (specific activity, 1-3xl0 8 cpm//jg) labeled by the random priming method (28) . Filters were washed twice with 2xSSC/0.2%SDS at room temperature, twice with 0.2xSSC/0.2%SDS at 55°C and exposed to Fuji RX X-ray films with intensifying screens at -70°C.
RESULTS

Isolation of the cDNA encoding E1A enhancer binding protein, E1A-F
HeLa cell Xgtll expression library was screened by using catenated El A enhancer core elements that contained either wild type or mutant sequences (Fig. 1) . About 1.2 x 10 6 plaques were screened in non-denaturing binding buffer without guanidine-HCl according to Singh et al.(18) . Several phage plaques were positive in the first screening. After four rounds of plaque purifications, only one clone, designated X3-16, bound to the wild type probe (F-wt) though not to the mutant probe (F-mut) (Fig.lB) . Thus the X3-16 was a candidate for the cDNA clone to encode E1A-F.
Binding specificity of the X3-16 /3-galactosidase fusion protein to E1A enhancer core sequences In order to analyse the DNA binding specificity of die cDNAencoding protein, lysogens were isolated with die X3-16 and Xgtl 1 vector phages. Extracts of the IPTG-induced lysogens, which were expected to contain /3-galactosidase fusion protein, were subjected to gel retardation assays. As shown in Figure 2 , extract of the X3-16 lysogen contained the binding activity to ^P-labeled F-wt but not to the F-mut, as well as DNA-affinity chromatography fraction of HeLa cell El A-F (Fig.2 , lanes 2 and 8, lanes 9 and 10). The binding activity was not detected in the (18) . The X3-16 plaques were lifted onto a nitrocellulose filter and probed with F-wt DNA containing three tandem copies of two E1A enhancer core elements (5'-AGGAAGT-3' and 5'-CGGATGT-3'). A half of the filter was also probed with 32 P-labeled F-mut DNA containing two tandem copies of mutant core elements (5'-ACCAAGT-3' and S'-CCCATGT-S'). Filters were exposed overnight to X ray films at -70°C. were incubated with ^P-labded F-wt (lanes 1 -7 and 9) and F-mut probes (lanes 8 and 10). DNA-protein complex(C) was separated from free probe(F) by 4% PAGE. For competition, excess molar amounts of unlabeled F-wt (lanes 3-6) or F-mut (lane 7) were added as indicated.
Xgtll lysogen extract (Fig.2, lane 1) . For specific binding, molarexcess amounts of competitor oligonucleotides were added in binding reactions. A 20-fold molar excess of F-wt competitor almost completely eliminated the binding activity (Fig.2 , lane 4), while F-mut DNA had little effect even in the 200-fold molar excess amount (Fig.2, lane 7) . Almost similar profiles of competition were obtained when probed with the Ad5 Rsal/Sspl fragment containing El A enhancer element (-303 to -158 relative to the El A cap site)(data not shown).
The binding site of X3-16 /3-galactosidase fusion protein was determined by the methylation interference assay and compared with that of El A-F protein endogenous to HeLa cells. The Ad5 Rsal/Sspl fragment, partially methylated with DMS, was incubated with extracts of the X3-16 lysogen and endogenous HeLa cell El A-F. Free DNA and protein-DNA complexes were separated by gel electrophoresis. DNA was extracted, cleaved with piperidine and resolved in sequencing gels. Methylation of G residues at -298, -299, -268 and -269 affected DNAbinding with extracts of the X3-16 lysogen (Fig.3, lane 4) . These G residues resided in the E1A enhancer core elements (Fig. 1A) . The methylation effect was comparable with that obtained by HeLa cell E1A-F protein (compare Fig.3, lanes 3 and 4) . Similar methylation interferences were observed when probed with The boxed region denotes the ETS-domain common to all of the as oocogene members (13) . Acidic and glutamine-rich regions are underlined and putative ATPbinding domain was indicated by an arrow. A putative poly(A) signal (5'-AATAAA-3') is double underlined.
con turn fry *S*****LW*PLL*LL********I*H** T 1I1A-F 100% RRGA LQUIQPLVALLEOPTOAHFIAIfT GRGKEFKLIEPEHVA R1X0IQK HRJ>WOrTDILSR3LRinnfEKGIMQlCVAG7i»YVYKFV 62% catenated El A enhancer core elements (data not shown). These results showed that the cloned cDNA encoded a El A enhancer binding protein almost identical in binding specificity with El A-F protein endogenous to HeLa cells.
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Nucleotide sequences of E1A-F cDNA
The X3-16 clone contained about a 0.46kb-long cDNA, which was considerably shorter than the full length cDNA as estimated from the size of mRNA (Fig.6, approximately 2.5kb) . Further Figure 6 . Activation of the ElA enhancer core element-containing SV40 core promoter by cloned ElA-F protein. CAT reporter constructs with wild-type or mntntw< ElA enhancer core elements were transfected into 293 ceDs with or without the pCMVElA-F plasmid expressing ElA-F protein, using the calcium phosphate precipitation technique described in Materials and Methods. CAT activity was measured 48hr after transfection and expressed in relation to the basal activity of the SV40 core promoter with wild-type E1A enhancer core element (6xF-wt). Experiments were repeated diree times with similar quantitative results. One representative autoradiograph is shown. Abbreviations: 6xF-wt, six tandem copies of wild-type ElA enhancer core element; 2xF-mut, two tandem copies of mutant ElA enhancer core element.
acids. Judging from the molecular mass of the HeLa cell ElA-F protein (60kD, unpublished data), we estimated dial the ElA-F cDNA clone may lack a coding sequence for about 90 amino acids on the amino-terrninal of the ORF. Following the stop codon at nucleotide (nt) 1387(TAG), the 3' non-coding region of me cDNA comprised 704bp including a 29nt poly(A) tail and a putative poly(A) signal at nt 2040. A computer search using the Genbank and NBRF databases revealed that the carboxyl-terminal region had high homology with the ETS-domain common to the members of ets oncogene family (Fig.4, boxed region) . The ETSdomain consists of about 85 amino acids and is involved in sequence-specific DNA binding (13) . Figure 5 shows the homology in the ETS-domain between the ElA-F and other ets oncogene members. ElA-F has an approximately 60% identity with ets-l(3l), ets-2 (32, 33) , erg (34) , elk (35) and GABPa(36), though only a 32% identity with PU.1 (37) . Twenty-five of twenty-seven ETS consensus amino acids were conserved in E1A-F. The ElA-F ETS-domain was identical to that of the polyomavirus(Py) enhancer activator 3 (PEA3, ref.38) (Fig.5) . Acidic and glutanime-rich regions were also conserved in E1A-F and PEA3 (Fig.4 , amino acid numbers 27 to 53 and 126 to 222, underlined). Overall, diere was an about 94% identity in amino acids between them (ElA-F: 462 residues determined so far; PEA3: 555 residues). ElA-F may be a human homologue of mouse PEA3.
Transcriptional activation by ElA-F
To elucidate whether ElA-F could activate the promoter, we performed transient expression assay in human 293 cells by cotransfection of effector and reporter plasmids. Human 293 cells do not express ElA-F mRNA (Fig.7B, lane 6) . The effector expression plasmid (pCMVElA-F) contains the cytomegalovirus promoter, the herpes thymidine kinase untranslated leader sequence and initiation codon, the coding region of the ElA-F cDNA, which is 453 amino acids long, and the 0-globin splicing and poly (A) signals. The reporter CAT plasmids contain the SV40 early core promoter carrying six tandem copies of wildNucleic Acids Research, 1993, Vol. 21, No. 3 551 type ElA enhancer core elements (6 x F-wt) or two tandem copies of mutant ElA-F enhancer core elements (2xF-mut): these sites are positioned approximately 140bp upstream of the SV40 early RNA start site. As shown in Figure 6 , the SV40 core promoter with wild-type ElA enhancer core elements was activated an average of 3.4-fold by co-transfection with pCMVElA-F. However, ElA-F has little effect on the activity of the SV40 core promoter with mutant ElA enhancer core elements. These results indicate that ElA-F is capable of activating the SV40 core promoter through ElA-F binding sites.
Effects of adenovirus infection on the expression of ElA-F gene
Assuming that the cloned ElA-F gene encodes an activator for ElA gene transcription, the expression of ElA-F can be increased by Ad infection in parallel with an activation of the ElA gene. HeLa cells were infected with Ad5 and Ad5 dl312 mutant and cytoplasmic RNA was extracted at different times after infections. RNA was analyzed by Northern blot hybridization with n Plabeled Ad5 ElA DNA, ElA-F cDNA and human ets-2 cDNA (Fig.7) . Ets-2 is a member of the ets oncogene family and is expressed in many kinds of cells with different origins. A blot was also probed with human /3-actin to ensure equal loading of RNA. An about 2.5kb mRNA was clearly detected with ElA-F cDNA probe in HeLa cells (Fig.7B, lane 1) , but was not found in 293 cells (Fig.TB, lane 6) . No detectable hybridization was obtained in the 293 cells under stringent conditions even when 10/tg of polyA-containing RNA was used (data not shown). Ets-2 specific mRNA (4.7, 3.2 and 2.7kb, ref.39) was detected in both HeLa and 293 cells (Fig.7C, lanes 1 and 6) . Ad5 ElA mRNA was detectable at 3hr post-infection by longer exposure to a Xray film and after that increased gradually (Fig.7A) . ElA-F mRNA increased in some extent (about 2 fold) during early times of Ad5 infections (Fig.7B, lanes 1-5) , while ets-2 mRNA reduced significantly with delay at the first 3hr post-infection (Fig.7C, lanes 1-5) . Levels of E1A-F and ets-2 mRNA did not change by infection with El A gene-deleted Ad5 mutant, dl312 ( Fig.7B and C, lanes 7 -11) , suggesting differential regulation of ets oncogene members by Ad5 E1A. The results support the idea that E1A-F gene encodes an activator for transcription of Ad E1A gene.
DISCUSSION
We have isolated the cDNA which encodes the Ad El A enhancerbinding protein, E1A-F. The deduced amino acid sequences showed high homology with the ETS-domain, the DNA binding region in the ets oncogenes. The ETS-domain is about 85 amino acids long (13) ; it contains three tryptophan repeats spaced 18 or 19 residues apart in the ammo-terminal half and is rich in basic amino acids in the carboxyl-terminal half (13) . Furthermore, E1A-F conserves virtually all of the structural features of the ETSdomain (Fig.5) . Therefore, we conclude that E1A-F is a member of the ets oncogene family.
Other domains to be found in such genes have been enumerated by Sethetal., who predicted the presence of an amphipathic helixloop-helix, a cell division motif, a nuclear localization signal, an ATP-binding domain and a Cx type metal-binding finger (40) . ATP-binding domains exist in many kinds of kinases, containing glycine-rich sequences with the consensus motif of GXGXXG (41) . At 10 to 15 amino acids apart from the carboxylterminal of this motif, a conserved lysine residue is present. In E1A-F, ATP-binding like domain was observed upstream of the ETS-domain (GDGAMG, see Fig.4 ) and a lysine residue was found 20 amino acids downstream of the consensus motif. No other putative domains have yet been established in E1A-F.
Amino acid sequences of E1A-F showed striking homology (about 94% identity) with that of mouse PEA3 (38) . Furthermore, the ETS-domain of E1A-F and PEA3 proteins was identical. Since the PEA3 motif overlapped El A enhancer core sequence (5, 6, 8, 12) , it seems reasonable to conclude that El A-F is a human homologue of mouse PEA3. Acidic and glutaminerich regions resided in the amino-terminal side of mouse PEA3 (38) . These amino acids generally constitute activation domains of transcription factors (42, 43) . Both acidic and glutamine-rich regions were also conserved in E1A-F (Fig.4) . The acidic region was the same as that of PEA3, but the glutamine-rich region was slightly different (86% identity). Indeed, exogenous expression of E1A-F was found to activate the CAT reporter gene through multimers of El A-F sites (see Fig.6 ). These domains may play an important role in transcriptional activation. However, further experiment is required to elucidate the role of El A-F in the regulation of El A gene expression.
It is interesting that two members of the ets oncogene family, E1A-F and ets-2, were oppositely influenced by Ad infection, and probably by the E1A gene. The expression of E1A-F was activated by El A, suggesting that El A may regulate itself positively through enhanced El A-F binding to enhancer elements. On the other hand, ets-2 mRNA was significantly decreased by E1A. E1A-F and ets-2 genes may have a reciprocal relationship in the regulation of Ad E1A gene. Xin et al. (38) found two mRNA species (2.4 and 4.1kb) in HeLa and 293 cells by hybridization with a mouse PEA3 probe. In this study, the 2.4kb mRNA was detectable in HeLa cells though not in 293 cells even when polyA-containing RNA was used. We also noted that the hybridization signal with the PEA3 probe was faint. The reason for this discrepancy is not clear. However, the possibility is that there is some variety of 293 cells dependent on laboratory growth conditions and thus selection pressures. A 4. lkb mRNA was observed in HeLa and 293 cells only under low stringent conditions adopted in the study of Xin et al. (38) (data not shown).
Bruder and Hearing (12) identified cellular protein(s) bound to Ad5 E1A enhancer element I, termed EF-1A. Watanabe et al. (44) purified HeLa cell protein bound to an Ad5 E4 transcription control element (5'-ACGGAAGTG-3'), termed E4TF1. EF-1A, E4TF1 and El A-F in this study recognize common or related sequences. It remains to be resolved what role, if any, they play in the activation of the El A gene. Ets-l and -2 oncogenes activated the Py enhancer through the PEA3-binding motif (15) . The cloned mouse PEA3 gene also activated artificial promoter through the PEA3-binding motif (38) . It is possible that Ad E1A enhancer harboring 5'-A /cGGA A /tGT-3' sites is recognized and regulated by multiple members of the ets oncogene family.
